<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schissler AG</submitter><funding>NCI NIH HHS</funding><funding>NLM NIH HHS</funding><pagination>i80-i89</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4908332</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>32(12)</volume><pubmed_abstract>&lt;h4>Motivation&lt;/h4>As 'omics' biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation, limiting opportunities for translation of single-cell transcriptomic insights to precision medicine. Lastly, most single-cell RNA-sequencing analytic approaches are not designed to investigate small populations of cells such as circulating tumor cells shed from solid tumors and isolated from patient blood samples.&lt;h4>Results&lt;/h4>In response to these characteristics and limitations in current single-cell RNA-sequencing methodology, we introduce an analytic framework that models transcrip</pubmed_abstract><journal>Bioinformatics (Oxford, England)</journal><pubmed_title>Analysis of aggregated cell-cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells.</pubmed_title><pmcid>PMC4908332</pmcid><funding_grant_id>K22 LM008308</funding_grant_id><funding_grant_id>P30 CA023074</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Lussier YA</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Billheimer DD</pubmed_authors><pubmed_authors>Piegorsch WW</pubmed_authors><pubmed_authors>Kenost C</pubmed_authors><pubmed_authors>Schissler AG</pubmed_authors><pubmed_authors>Chen JL</pubmed_authors><pubmed_authors>Achour I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of aggregated cell-cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells.</name><description>&lt;h4>Motivation&lt;/h4>As 'omics' biotechnologies accelerate the capability to contrast a myriad of molecular measurements from a single cell, they also exacerbate current analytical limitations for detecting meaningful single-cell dysregulations. Moreover, mRNA expression alone lacks functional interpretation, limiting opportunities for translation of single-cell transcriptomic insights to precision medicine. Lastly, most single-cell RNA-sequencing analytic approaches are not designed to investigate small populations of cells such as circulating tumor cells shed from solid tumors and isolated from patient blood samples.&lt;h4>Results&lt;/h4>In response to these characteristics and limitations in current single-cell RNA-sequencing methodology, we introduce an analytic framework that models transcrip</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jun</publication><modification>2026-05-30T08:32:12.526Z</modification><creation>2019-03-27T02:16:04Z</creation></dates><accession>S-EPMC4908332</accession><cross_references><pubmed>27307648</pubmed><doi>10.1093/bioinformatics/btw248</doi></cross_references></HashMap>